BNP/PUT/FRESENIUS MEDICAL CARE/46/0.1/21.06.24 Stock

Warrant

DE000PE801N2

Delayed Deutsche Boerse AG 09:21:03 2024-06-17 EDT
0.87 EUR +17.57% Intraday chart for BNP/PUT/FRESENIUS MEDICAL CARE/46/0.1/21.06.24
Current month+10.45%
1 month+21.31%
Date Price Change
24-06-17 0.87 +17.57%
24-06-14 0.74 +2.78%
24-06-13 0.72 +20.00%
24-06-12 0.6 -10.45%
24-06-11 0.67 +3.08%

Delayed Quote Deutsche Boerse AG

Last update June 17, 2024 at 09:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE801N
ISINDE000PE801N2
Date issued 2023-02-13
Strike 46
Maturity 2024-06-21 (4 Days)
Parity 10 : 1
Emission price 1.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.52
Lowest since issue 0.34
Spread 0.04
Spread %4.44%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.63 EUR
Average target price
39.97 EUR
Spread / Average Target
+3.48%
Consensus